MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Korro Bio, Inc. (KRRO)

Korro Bio, Inc. (KRRO)

|||

Balance Sheets Overview

Current Ratio
812.63%
Quick Ratio
812.63%
Cash Ratio
417.24%
Debt to Asset Ratio
34.85%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Short-term marketable securities
    • Long-term marketable securities
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
61,697 21,824 24,155 33,612
Short-term marketable securities
52,273 53,332 68,324 62,750
Accounts receivable
0 969 820 1,089
Prepaid expenses and other current assets
6,193 6,247 4,927 5,183
Total current assets
120,163 82,372 98,226 102,634
Total property and equipment, gross
18,754 18,733 35,357 NaN
Less accumulated depreciation
10,949 10,569 10,959 NaN
Property and equipment, net
7,805 8,164 24,398 25,395
Operating lease right-of-use assets
7,816 8,058 23,332 23,510
Restricted cash, net of current portion
2,409 2,409 2,409 2,409
Long-term marketable securities
43,083 10,031 10,014 23,264
Other non-current assets
2,346 2,472 3,171 3,213
Total assets
183,622 113,506 161,550 180,425
Accounts payable
1,957 1,651 2,300 5,163
Accrued expenses and other current liabilities
9,850 7,614 5,861 5,659
Operating lease liabilities, current portion
2,801 2,672 3,145 2,425
Deferred revenue, current portion
179 0 3,332 3,926
Total current liabilities
14,787 11,937 14,638 17,173
Operating lease liabilities, net of current portion
40,084 40,814 41,523 42,207
Deferred revenue, non current portion
7,656 7,835 4,825 4,502
Other non-current liabilities
1,462 1,481 1,532 1,440
Total liabilities
63,989 62,067 62,518 65,322
Common stock, 0.001 par value 200,000,000 shares authorized at march 31, 2026 and december 31, 2025 14,422,571 shares and 9,417,295 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
14 9 9 9
Additional paid-in capital
523,085 435,064 432,613 430,660
Accumulated other comprehensive income
5 212 214 177
Accumulated deficit
-403,471 -383,846 -333,804 -315,743
Total stockholders' equity
119,633 51,439 99,032 115,103
Total liabilities and stockholders' equity
183,622 113,506 161,550 180,425
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$61,697K Short-term marketablesecurities$52,273K Prepaid expenses andother current assets$6,193K Total property andequipment, gross$18,754K Total current assets$120,163K Long-term marketablesecurities$43,083K Operating leaseright-of-use assets$7,816K Property and equipment,net$7,805K Restricted cash, net ofcurrent portion$2,409K Other non-currentassets$2,346K Less accumulateddepreciation$10,949K Total assets$183,622K Total liabilities andstockholders' equity$183,622K Total stockholders'equity$119,633K Total liabilities$63,989K Accumulated deficit-$403,471K Additional paid-in capital$523,085K Operating leaseliabilities, net of current...$40,084K Total currentliabilities$14,787K Deferred revenue, noncurrent portion$7,656K Other non-currentliabilities$1,462K Common stock, 0.001 parvalue 200,000,000...$14K Accumulated othercomprehensive income$5K Accrued expenses andother current...$9,850K Operating leaseliabilities, current portion$2,801K Accounts payable$1,957K Deferred revenue,current portion$179K